IRADIMED CORPORATION (NASDAQ:IRMD) Files An 8-K Results of Operations and Financial Condition

IRADIMED CORPORATION (NASDAQ:IRMD) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02 Results of Operations and Financial
Condition.

On February6, 2017,IRADIMED CORPORATION (the Company) issued a
press release announcing its financial results for the fourth
quarter ended December31, 2016. A copy of the press release is
furnished as Exhibit99.1 to this Current Report on Form8-K.

The information in this Item 2.02 and the exhibit attached hereto
shall not be deemed filed for purposes of Section18 of the
Securities Exchange Act of 1934 (the Exchange Act) or otherwise
subject to the liabilities of that Section, nor shall it be
deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and
Exhibits.

(d) Exhibits

99.1

Press release dated February6, 2017 announcing the Companys
results of operations for its fourth quarter ended
December31, 2016.


About IRADIMED CORPORATION (NASDAQ:IRMD)

IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.

IRADIMED CORPORATION (NASDAQ:IRMD) Recent Trading Information

IRADIMED CORPORATION (NASDAQ:IRMD) closed its last trading session down -0.10 at 8.85 with 77,168 shares trading hands.

An ad to help with our costs